Search Within

Andrew Jeffrey Dunbar

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (5)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (14)
  2. Department of Medicine (14)
  3. Hematologic Malignancies, Division of (14)
  4. Sloan Kettering Institute Postdocs (14)
  5. Adult Leukemia (13)
  6. Executive Committee, Center for Hematologic Malignancies (13)

More Groups

People
  1. Ross Levine (13)
  2. Sheng Cai (8)
  3. Sean Devlin (7)
  4. Wenbin Xiao (7)
  5. Erin McGovern (6)
  6. Jacob Glass (6)

More People

Years
  1. 2024 (4)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (2)
  6. 2019 (2)

More Years

Publications
  1. Blood (7)
  2. Haematologica (2)
  3. American Journal of Hematology (1)
  4. Cancer Cell (1)
  5. Cancer Discovery (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. American Association for Cancer Research (2)
  3. Ferrata Storti Foundation (2)
  4. Cell Press (1)
  5. John Wiley & Sons, Inc. (1)
  6. Nature Publishing Group (1)

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy
    Journal Article

    Bowman, R. L.; Dunbar, A. J.; Mishra, T.; Xiao, W.; Waarts, M. R.; Maestre, I. F.; Eisman, S. E.; Cai, L.; Mowla, S.; Shah, N.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Mapping genotypes to chromatin accessibility profiles in single cells
    Journal Article

    Izzo, F.; Myers, R. M.; Ganesan, S.; Mekerishvili, L.; Kottapalli, S.; Prieto, T.; Eton, E. O.; Botella, T.; Dunbar, A. J.; Bowman, R. L.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Jak2(V617F) reversible activation shows its essential requirement in myeloproliferative neoplasms
    Journal Article

    Dunbar, A. J.; Bowman, R. L.; Park, Y. C.; O'Connor, K.; Izzo, F.; Myers, R. M.; Karzai, A.; Zaroogian, Z.; Kim, W. J.; Fernandez-Maestre, I.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Development of resistance to type II JAK2 inhibitors in MPN depends on AXL kinase and is targetable
    Journal Article

    Codilupi, T.; Szybinski, J.; Arunasalam, S.; Jungius, S.; Dunbar, A. C.; Stivala, S.; Brkic, S.; Albrecht, C.; Vokalova, L.; Yang, J. L.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis
    Journal Article

    Dunbar, A. J.; Kim, D.; Lu, M.; Farina, M.; Bowman, R. L.; Yang, J. L.; Park, Y.; Karzai, A.; Xiao, W.; Zaroogian, Z.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • JAK2(V617F) reversible activation shows an essential requirement for JAK2(V617F) in myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Dunbar, A.; Bowman, R. L.; Park, Y.; Izzo, F.; Myers, R. M.; Karzai, A.; Kim, W. J.; Maestre, I. F.; Waarts, M. R.; Nazir, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors
    Journal Article

    Dunbar, A.; Bolton, K. L.; Devlin, S. M.; Sanchez-Vega, F.; Gao, J.; Mones, J. V.; Wills, J.; Kelly, D.; Farina, M.; Cordner, K. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Mathematical modeling reveals alternative JAK inhibitor treatment in myeloproliferative neoplasms
    Research Letter

    Shank, K.; Dunbar, A.; Koppikar, P.; Kleppe, M.; Teruya-Feldstein, J.; Csete, I.; Bhagwat, N.; Keller, M.; Kilpivaara, O.; Michor, F.; more...
    Haematologica (2020)

    Fulltext@MSK | Save